Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
24.05
+1.98 (8.97%)
Mar 9, 2026, 2:56 PM EDT - Market open
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $2.12 billion as of March 9, 2026. Its market cap has increased by 55.41% in one year.
Market Cap
2.12B
Enterprise Value
2.11B
1-Year Change
55.41%
Ranking
Category
Stock Price
$24.05
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $2.12B, an increase of 916.89%. That is a compound annual growth rate of 26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.95B | 6.60% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 2.29B |
| Adaptive Biotechnologies | 2.22B |
| Day One Biopharmaceuticals | 2.20B |
| Ultragenyx Pharmaceutical | 2.18B |
| Stoke Therapeutics | 2.17B |
| Ocular Therapeutix | 2.16B |
| Galapagos NV | 2.15B |
| Zai Lab | 2.14B |